5 fluorouracil Search Results


93
Gold Biotechnology Inc fu
Fu, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/10__59313_slash_jsr___a__1347817-66-0-4?v=Gold+Biotechnology+Inc
Average 93 stars, based on 1 article reviews
fu - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
LKT Laboratories 5 fu
5 Fu, supplied by LKT Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pmc08280155-214-44-45?v=LKT+Laboratories
Average 93 stars, based on 1 article reviews
5 fu - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

94
Tocris anti cancer drugs 5 fluorouracil
Anti Cancer Drugs 5 Fluorouracil, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pm41225774-111-0-5?v=Tocris
Average 94 stars, based on 1 article reviews
anti cancer drugs 5 fluorouracil - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

94
Tocris 5 fluorouracil
5 Fluorouracil, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pmc06291153-151-2-9?v=Tocris
Average 94 stars, based on 1 article reviews
5 fluorouracil - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology dnmt3a santa cruz sc 20703 wb
Dnmt3a Santa Cruz Sc 20703 Wb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pmc04466775__pone__0128745__s005-0-0-1?v=Santa+Cruz+Biotechnology
Average 92 stars, based on 1 article reviews
dnmt3a santa cruz sc 20703 wb - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

94
Thermo Fisher cytarabine
( A ) Graph of cell cycle kinetics data comparing Mubritinib (MUB) to <t>cytarabine</t> (CYT) and rapamycin (RAP). DMSO and camptothecin (CPT) were used as controls. PEL cells (BC1 and BCBL1) treated with 7.5 nM Mubritinib show a significant decrease in the total population of S and G2 cells that is not observed for BJAB or LCL352 cells. Neither cytarabine nor rapamycin showed similar selectivity for inhibition of PEL cell growth (S, G2) ( ** p < 0.001, * p < 0.05; Student’s T Test). ( B ) Cell cycle profiles comparing cells (BJAB, BC1, BCBL1, and LCL352) treated with DMSO and 15 nM Mubritinib measured by FACS flow cytometry analysis of propidium iodide staining. ( C ) Flow cytometry analysis of Annexin V/PI staining comparing cells (BJAB, BC1, BCBL1, LCL352) treated with DMSO and 15 nM Mubritinib. ( D ) Graphs summarizing the decrease in live cell populations observed from the Annexin V/PI experiment. Camptothecin (4 mM) and Cytarabin (1 mM) are shown for comparison. ( ** p < 0.001; Mann–Whitney). ( E ) ChIP-qPCR assay for LANA or IgG control in BCBL1 cells treated with Mubritinib (15 nM) for 72 hrs with primers for KSHV TR, control region a, or cellular Actin. ( F ) Western blot control of ChIP assays showing LANA, RTA, Actin, or gH2AX in BCBL1 cells at 48 h after addition of DMSO (–) or Mubritinib (15 nM) (+).
Cytarabine, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pmc07679036-171-3-8?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
cytarabine - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

91
Enamine Ltd reference compounds
( A ) Graph of cell cycle kinetics data comparing Mubritinib (MUB) to <t>cytarabine</t> (CYT) and rapamycin (RAP). DMSO and camptothecin (CPT) were used as controls. PEL cells (BC1 and BCBL1) treated with 7.5 nM Mubritinib show a significant decrease in the total population of S and G2 cells that is not observed for BJAB or LCL352 cells. Neither cytarabine nor rapamycin showed similar selectivity for inhibition of PEL cell growth (S, G2) ( ** p < 0.001, * p < 0.05; Student’s T Test). ( B ) Cell cycle profiles comparing cells (BJAB, BC1, BCBL1, and LCL352) treated with DMSO and 15 nM Mubritinib measured by FACS flow cytometry analysis of propidium iodide staining. ( C ) Flow cytometry analysis of Annexin V/PI staining comparing cells (BJAB, BC1, BCBL1, LCL352) treated with DMSO and 15 nM Mubritinib. ( D ) Graphs summarizing the decrease in live cell populations observed from the Annexin V/PI experiment. Camptothecin (4 mM) and Cytarabin (1 mM) are shown for comparison. ( ** p < 0.001; Mann–Whitney). ( E ) ChIP-qPCR assay for LANA or IgG control in BCBL1 cells treated with Mubritinib (15 nM) for 72 hrs with primers for KSHV TR, control region a, or cellular Actin. ( F ) Western blot control of ChIP assays showing LANA, RTA, Actin, or gH2AX in BCBL1 cells at 48 h after addition of DMSO (–) or Mubritinib (15 nM) (+).
Reference Compounds, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pmc10572347-494-35-40?v=Enamine+Ltd
Average 91 stars, based on 1 article reviews
reference compounds - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

94
Gold Biotechnology Inc f 230 25
( A ) Graph of cell cycle kinetics data comparing Mubritinib (MUB) to <t>cytarabine</t> (CYT) and rapamycin (RAP). DMSO and camptothecin (CPT) were used as controls. PEL cells (BC1 and BCBL1) treated with 7.5 nM Mubritinib show a significant decrease in the total population of S and G2 cells that is not observed for BJAB or LCL352 cells. Neither cytarabine nor rapamycin showed similar selectivity for inhibition of PEL cell growth (S, G2) ( ** p < 0.001, * p < 0.05; Student’s T Test). ( B ) Cell cycle profiles comparing cells (BJAB, BC1, BCBL1, and LCL352) treated with DMSO and 15 nM Mubritinib measured by FACS flow cytometry analysis of propidium iodide staining. ( C ) Flow cytometry analysis of Annexin V/PI staining comparing cells (BJAB, BC1, BCBL1, LCL352) treated with DMSO and 15 nM Mubritinib. ( D ) Graphs summarizing the decrease in live cell populations observed from the Annexin V/PI experiment. Camptothecin (4 mM) and Cytarabin (1 mM) are shown for comparison. ( ** p < 0.001; Mann–Whitney). ( E ) ChIP-qPCR assay for LANA or IgG control in BCBL1 cells treated with Mubritinib (15 nM) for 72 hrs with primers for KSHV TR, control region a, or cellular Actin. ( F ) Western blot control of ChIP assays showing LANA, RTA, Actin, or gH2AX in BCBL1 cells at 48 h after addition of DMSO (–) or Mubritinib (15 nM) (+).
F 230 25, supplied by Gold Biotechnology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/bio_rxiv__007310-111-42-41?v=Gold+Biotechnology+Inc
Average 94 stars, based on 1 article reviews
f 230 25 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Valiant Co Ltd 5 fluorouracil
( A ) Graph of cell cycle kinetics data comparing Mubritinib (MUB) to <t>cytarabine</t> (CYT) and rapamycin (RAP). DMSO and camptothecin (CPT) were used as controls. PEL cells (BC1 and BCBL1) treated with 7.5 nM Mubritinib show a significant decrease in the total population of S and G2 cells that is not observed for BJAB or LCL352 cells. Neither cytarabine nor rapamycin showed similar selectivity for inhibition of PEL cell growth (S, G2) ( ** p < 0.001, * p < 0.05; Student’s T Test). ( B ) Cell cycle profiles comparing cells (BJAB, BC1, BCBL1, and LCL352) treated with DMSO and 15 nM Mubritinib measured by FACS flow cytometry analysis of propidium iodide staining. ( C ) Flow cytometry analysis of Annexin V/PI staining comparing cells (BJAB, BC1, BCBL1, LCL352) treated with DMSO and 15 nM Mubritinib. ( D ) Graphs summarizing the decrease in live cell populations observed from the Annexin V/PI experiment. Camptothecin (4 mM) and Cytarabin (1 mM) are shown for comparison. ( ** p < 0.001; Mann–Whitney). ( E ) ChIP-qPCR assay for LANA or IgG control in BCBL1 cells treated with Mubritinib (15 nM) for 72 hrs with primers for KSHV TR, control region a, or cellular Actin. ( F ) Western blot control of ChIP assays showing LANA, RTA, Actin, or gH2AX in BCBL1 cells at 48 h after addition of DMSO (–) or Mubritinib (15 nM) (+).
5 Fluorouracil, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/bio_rxiv__2025__02__21__639572-58-9-11?v=Valiant+Co+Ltd
Average 96 stars, based on 1 article reviews
5 fluorouracil - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

91
Valiant Co Ltd foa against pfl44 rpc10 growth
A. ribbon model of subunit P from Sulfolobus solfataricus ( Hirata et al ., 2008 ) generated using PyMOL. In the Sulfolobus structure the corresponding structural elements of the Pyrococcus subunit analysed and mutated in this study are shown with side chains and labelled by colours. A 17-amino-acid C-terminal peptide analyzed here is shown in yellow, the N-terminus in green, the cysteine residues 27 and 30 of the zinc-ribbon motif which were replaced by S are shown in red, R26 replaced by A in blue and S32 (Y in Sulfolobus ) replaced by A in black. B. alignment of the protein sequence of P subunits from eight archaeal species and two yeast Rpb12 <t>(Rpc10)</t> sequences. The alignment was generated using ClustalW version 2.0 ( Larkin et al. , 2007 ). The alignment was displayed using the ESPript software ( Gouet et al ., 1999 ). The consensus sequence displayed was calculated with Risler matrix and a similarity global score of 0.75% (uppercase is identity, lowercase is consensus level). The sequence of the C-terminal peptide analyzed in cell-free transcription assays is labelled with a yellow box and the single point mutations introduced into subunit P are indicated with arrows. The numbers in the first line indicate the Pyrococcus furiosus RpoP amino acid sequence from 1 to 49. The numbers in the last line shown in italics indicate the Saccharomyces cerevisiae Rpb12 amino acid sequence from position 1 to 70.
Foa Against Pfl44 Rpc10 Growth, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pmc02680338-189-18-12?v=Valiant+Co+Ltd
Average 91 stars, based on 1 article reviews
foa against pfl44 rpc10 growth - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

92
Biosynth Carbosynth 5 fluorouracil
A. ribbon model of subunit P from Sulfolobus solfataricus ( Hirata et al ., 2008 ) generated using PyMOL. In the Sulfolobus structure the corresponding structural elements of the Pyrococcus subunit analysed and mutated in this study are shown with side chains and labelled by colours. A 17-amino-acid C-terminal peptide analyzed here is shown in yellow, the N-terminus in green, the cysteine residues 27 and 30 of the zinc-ribbon motif which were replaced by S are shown in red, R26 replaced by A in blue and S32 (Y in Sulfolobus ) replaced by A in black. B. alignment of the protein sequence of P subunits from eight archaeal species and two yeast Rpb12 <t>(Rpc10)</t> sequences. The alignment was generated using ClustalW version 2.0 ( Larkin et al. , 2007 ). The alignment was displayed using the ESPript software ( Gouet et al ., 1999 ). The consensus sequence displayed was calculated with Risler matrix and a similarity global score of 0.75% (uppercase is identity, lowercase is consensus level). The sequence of the C-terminal peptide analyzed in cell-free transcription assays is labelled with a yellow box and the single point mutations introduced into subunit P are indicated with arrows. The numbers in the first line indicate the Pyrococcus furiosus RpoP amino acid sequence from 1 to 49. The numbers in the last line shown in italics indicate the Saccharomyces cerevisiae Rpb12 amino acid sequence from position 1 to 70.
5 Fluorouracil, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/pm28553862-46-1-2?v=Biosynth+Carbosynth
Average 92 stars, based on 1 article reviews
5 fluorouracil - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

95
Chem Impex International urea
A. ribbon model of subunit P from Sulfolobus solfataricus ( Hirata et al ., 2008 ) generated using PyMOL. In the Sulfolobus structure the corresponding structural elements of the Pyrococcus subunit analysed and mutated in this study are shown with side chains and labelled by colours. A 17-amino-acid C-terminal peptide analyzed here is shown in yellow, the N-terminus in green, the cysteine residues 27 and 30 of the zinc-ribbon motif which were replaced by S are shown in red, R26 replaced by A in blue and S32 (Y in Sulfolobus ) replaced by A in black. B. alignment of the protein sequence of P subunits from eight archaeal species and two yeast Rpb12 <t>(Rpc10)</t> sequences. The alignment was generated using ClustalW version 2.0 ( Larkin et al. , 2007 ). The alignment was displayed using the ESPript software ( Gouet et al ., 1999 ). The consensus sequence displayed was calculated with Risler matrix and a similarity global score of 0.75% (uppercase is identity, lowercase is consensus level). The sequence of the C-terminal peptide analyzed in cell-free transcription assays is labelled with a yellow box and the single point mutations introduced into subunit P are indicated with arrows. The numbers in the first line indicate the Pyrococcus furiosus RpoP amino acid sequence from 1 to 49. The numbers in the last line shown in italics indicate the Saccharomyces cerevisiae Rpb12 amino acid sequence from position 1 to 70.
Urea, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/5+fluorouracil/10__1021_slash_acssuschemeng__2c01668-36-0-2?v=Chem+Impex+International
Average 95 stars, based on 1 article reviews
urea - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


( A ) Graph of cell cycle kinetics data comparing Mubritinib (MUB) to cytarabine (CYT) and rapamycin (RAP). DMSO and camptothecin (CPT) were used as controls. PEL cells (BC1 and BCBL1) treated with 7.5 nM Mubritinib show a significant decrease in the total population of S and G2 cells that is not observed for BJAB or LCL352 cells. Neither cytarabine nor rapamycin showed similar selectivity for inhibition of PEL cell growth (S, G2) ( ** p < 0.001, * p < 0.05; Student’s T Test). ( B ) Cell cycle profiles comparing cells (BJAB, BC1, BCBL1, and LCL352) treated with DMSO and 15 nM Mubritinib measured by FACS flow cytometry analysis of propidium iodide staining. ( C ) Flow cytometry analysis of Annexin V/PI staining comparing cells (BJAB, BC1, BCBL1, LCL352) treated with DMSO and 15 nM Mubritinib. ( D ) Graphs summarizing the decrease in live cell populations observed from the Annexin V/PI experiment. Camptothecin (4 mM) and Cytarabin (1 mM) are shown for comparison. ( ** p < 0.001; Mann–Whitney). ( E ) ChIP-qPCR assay for LANA or IgG control in BCBL1 cells treated with Mubritinib (15 nM) for 72 hrs with primers for KSHV TR, control region a, or cellular Actin. ( F ) Western blot control of ChIP assays showing LANA, RTA, Actin, or gH2AX in BCBL1 cells at 48 h after addition of DMSO (–) or Mubritinib (15 nM) (+).

Journal: Oncotarget

Article Title: Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism

doi: 10.18632/oncotarget.27815

Figure Lengend Snippet: ( A ) Graph of cell cycle kinetics data comparing Mubritinib (MUB) to cytarabine (CYT) and rapamycin (RAP). DMSO and camptothecin (CPT) were used as controls. PEL cells (BC1 and BCBL1) treated with 7.5 nM Mubritinib show a significant decrease in the total population of S and G2 cells that is not observed for BJAB or LCL352 cells. Neither cytarabine nor rapamycin showed similar selectivity for inhibition of PEL cell growth (S, G2) ( ** p < 0.001, * p < 0.05; Student’s T Test). ( B ) Cell cycle profiles comparing cells (BJAB, BC1, BCBL1, and LCL352) treated with DMSO and 15 nM Mubritinib measured by FACS flow cytometry analysis of propidium iodide staining. ( C ) Flow cytometry analysis of Annexin V/PI staining comparing cells (BJAB, BC1, BCBL1, LCL352) treated with DMSO and 15 nM Mubritinib. ( D ) Graphs summarizing the decrease in live cell populations observed from the Annexin V/PI experiment. Camptothecin (4 mM) and Cytarabin (1 mM) are shown for comparison. ( ** p < 0.001; Mann–Whitney). ( E ) ChIP-qPCR assay for LANA or IgG control in BCBL1 cells treated with Mubritinib (15 nM) for 72 hrs with primers for KSHV TR, control region a, or cellular Actin. ( F ) Western blot control of ChIP assays showing LANA, RTA, Actin, or gH2AX in BCBL1 cells at 48 h after addition of DMSO (–) or Mubritinib (15 nM) (+).

Article Snippet: Adrucil (228440010) and Cytarabine (449561000) were purchased from Acros Organics.

Techniques: Inhibition, Flow Cytometry, Staining, Comparison, MANN-WHITNEY, ChIP-qPCR, Control, Western Blot

A. ribbon model of subunit P from Sulfolobus solfataricus ( Hirata et al ., 2008 ) generated using PyMOL. In the Sulfolobus structure the corresponding structural elements of the Pyrococcus subunit analysed and mutated in this study are shown with side chains and labelled by colours. A 17-amino-acid C-terminal peptide analyzed here is shown in yellow, the N-terminus in green, the cysteine residues 27 and 30 of the zinc-ribbon motif which were replaced by S are shown in red, R26 replaced by A in blue and S32 (Y in Sulfolobus ) replaced by A in black. B. alignment of the protein sequence of P subunits from eight archaeal species and two yeast Rpb12 (Rpc10) sequences. The alignment was generated using ClustalW version 2.0 ( Larkin et al. , 2007 ). The alignment was displayed using the ESPript software ( Gouet et al ., 1999 ). The consensus sequence displayed was calculated with Risler matrix and a similarity global score of 0.75% (uppercase is identity, lowercase is consensus level). The sequence of the C-terminal peptide analyzed in cell-free transcription assays is labelled with a yellow box and the single point mutations introduced into subunit P are indicated with arrows. The numbers in the first line indicate the Pyrococcus furiosus RpoP amino acid sequence from 1 to 49. The numbers in the last line shown in italics indicate the Saccharomyces cerevisiae Rpb12 amino acid sequence from position 1 to 70.

Journal: Molecular Microbiology

Article Title: The archaeal RNA polymerase subunit P and the eukaryotic polymerase subunit Rpb12 are interchangeable in vivo and in vitro

doi: 10.1111/j.1365-2958.2008.06577.x

Figure Lengend Snippet: A. ribbon model of subunit P from Sulfolobus solfataricus ( Hirata et al ., 2008 ) generated using PyMOL. In the Sulfolobus structure the corresponding structural elements of the Pyrococcus subunit analysed and mutated in this study are shown with side chains and labelled by colours. A 17-amino-acid C-terminal peptide analyzed here is shown in yellow, the N-terminus in green, the cysteine residues 27 and 30 of the zinc-ribbon motif which were replaced by S are shown in red, R26 replaced by A in blue and S32 (Y in Sulfolobus ) replaced by A in black. B. alignment of the protein sequence of P subunits from eight archaeal species and two yeast Rpb12 (Rpc10) sequences. The alignment was generated using ClustalW version 2.0 ( Larkin et al. , 2007 ). The alignment was displayed using the ESPript software ( Gouet et al ., 1999 ). The consensus sequence displayed was calculated with Risler matrix and a similarity global score of 0.75% (uppercase is identity, lowercase is consensus level). The sequence of the C-terminal peptide analyzed in cell-free transcription assays is labelled with a yellow box and the single point mutations introduced into subunit P are indicated with arrows. The numbers in the first line indicate the Pyrococcus furiosus RpoP amino acid sequence from 1 to 49. The numbers in the last line shown in italics indicate the Saccharomyces cerevisiae Rpb12 amino acid sequence from position 1 to 70.

Article Snippet: The YCplac22 vector encoding TRP1 supported growth on tryptophan-free minimal media (SDC; MP Biomedicals) and after counterselection on FOA against pFL44- RPC10 growth was monitored at four temperatures (18, 25, 30 and 37°C) by plating on minimal media containing 5-fluoroorotic acid (1 g l −1 ; Toronto Research Chemicals) as described previously ( ).

Techniques: Generated, Sequencing, Software

Archaeal rpoP can complement the essential function of yeast RPB12. DNA regions encoding RpoP of Pyrococcus furiosus (C1) were fused with the strong yeast RPS28B promoter and inserted in the centromeric plasmid YCplac22. The resulting constructs were transformed into yeast strain YGVS019 carrying chromosomal deletion of RPB12 rescued by a RPB12 / URA3 plasmid (pFL44- RPC10 ). Transformants were transferred on 5-fluoroorotic acid containing plates to counterselect against plasmid pFL44- RPC10 and plates were incubated at 25°C for 5 days. The cells expressing RpoP (C1) showed growth comparable to cells expressing yeast RPB12 (C4) at 25°C and reduced growth at 37°C (data not shown). A similar construct with a chimeric gene encoding for the N-terminal domain of Rpb12 fused with rpoP of Pyrococcus (C3) could also complement the essential function of RPB12 and did not lead to temperature sensitive growth phenotype. The N-terminal domain coding region of RPB12 alone (C2) could not complement the essential functions of RPB12 .

Journal: Molecular Microbiology

Article Title: The archaeal RNA polymerase subunit P and the eukaryotic polymerase subunit Rpb12 are interchangeable in vivo and in vitro

doi: 10.1111/j.1365-2958.2008.06577.x

Figure Lengend Snippet: Archaeal rpoP can complement the essential function of yeast RPB12. DNA regions encoding RpoP of Pyrococcus furiosus (C1) were fused with the strong yeast RPS28B promoter and inserted in the centromeric plasmid YCplac22. The resulting constructs were transformed into yeast strain YGVS019 carrying chromosomal deletion of RPB12 rescued by a RPB12 / URA3 plasmid (pFL44- RPC10 ). Transformants were transferred on 5-fluoroorotic acid containing plates to counterselect against plasmid pFL44- RPC10 and plates were incubated at 25°C for 5 days. The cells expressing RpoP (C1) showed growth comparable to cells expressing yeast RPB12 (C4) at 25°C and reduced growth at 37°C (data not shown). A similar construct with a chimeric gene encoding for the N-terminal domain of Rpb12 fused with rpoP of Pyrococcus (C3) could also complement the essential function of RPB12 and did not lead to temperature sensitive growth phenotype. The N-terminal domain coding region of RPB12 alone (C2) could not complement the essential functions of RPB12 .

Article Snippet: The YCplac22 vector encoding TRP1 supported growth on tryptophan-free minimal media (SDC; MP Biomedicals) and after counterselection on FOA against pFL44- RPC10 growth was monitored at four temperatures (18, 25, 30 and 37°C) by plating on minimal media containing 5-fluoroorotic acid (1 g l −1 ; Toronto Research Chemicals) as described previously ( ).

Techniques: Plasmid Preparation, Construct, Transformation Assay, Incubation, Expressing